Check out the companies making headlines before the bell. Micron — Shares slipped nearly 6% after the semiconductor manufacturer posted revenue guidance of $7.6 billion for its current quarter, coming in line with analyst expectations. Micron also reported a third-quarter earnings and revenue beat. GSK — Shares of the biopharmaceutical company slid nearly 2% after the Centers for Disease Control and Prevention held off on recommending RSV vaccines for adults younger than 60. Levi Strauss — The denim maker’s stock tumbled 15.4% after revenue came in at $1.44 billion for the second fiscal quarter, slightly under the consensus forecast of $1.45 billion from analysts polled by LSEG. International Paper — The paper manufacturing company dropped 13% after Suzano decided to terminate negotiations for a potential acquisition. Suzano said it had reached the maximum price for the transaction to general value without having heard from the other party. Walgreens Boots Alliance — Shares tumbled more than 11% after the retail pharmacy company reported a third-quarter earnings miss and cut its full-year adjusted profit outlook. Walgreens also said it would close underperforming stores to cut costs. Goldman Sachs — The U.S. banking stock slipped nearly 2% after the latest round of stress test results . The Federal Reserve said that the 31 biggest banks in the U.S. could all withstand a hypothetical severe recession. AeroVironment — Shares tumbled 6% despite the unmanned aerial vehicles manufacturer reporting a fourth-quarter earnings and revenue beat. However, the company reported EBITDA guidance for its fiscal year 2025 that was 5% lower than analyst consensus estimates, according to FactSet. U.S. Bancorp — The bank stock slipped more than 1% following a downgrade to neutral from overweight at J.P. Morgan. Analyst Vivek Juneja said the bank could face pressure due to stiffer capital requirements from stress tests. — CNBC’s Michelle Fox, Alex Harring and Fred Imbert contributed reporting.